Tumor Viral Infections

Several viruses are known to be associated with the development of certain cancers, leading to what is commonly referred to as tumor viral infections. Human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV), and human herpesvirus 8 (HHV-8) are among the well-established oncoviruses. HPV is strongly linked to cervical cancer, as well as cancers of the vulva, vagina, penis, anus, and oropharynx. The integration of HPV DNA into host cells' genome contributes to the transformation of normal cells into cancerous ones. Vaccination against high-risk HPV types has become a crucial preventive measure. HBV and HCV are major contributors to hepatocellular carcinoma (liver cancer). Chronic infection with these viruses can lead to cirrhosis, increasing the risk of liver cancer development. Vaccination against HBV, antiviral treatments, and public health strategies to reduce viral transmission are essential in preventing virus-related liver cancers. EBV is associated with several malignancies, including Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma. The virus can immortalize B cells, contributing to lymphomagenesis. HHV-8 is linked to Kaposi's sarcoma, particularly in individuals with immunosuppression. Understanding the mechanisms by which oncoviruses contribute to cancer development is crucial for developing targeted therapies and preventive measures. Research focuses on antiviral drugs, vaccines, and strategies to modulate the host immune response to control or eliminate virus-associated tumors.